Ebos Group (ASX:EBO) FCF Yield %: 5.90 (As of Jun. 27, 2026) — 47% Above Median


ASX:EBO Ebos Group Ltd ASX:EBO
77 GF Score
Price A$16.76
GF Value A$31.49
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ebos Group FCF Yield %?

Ebos Group ASX:EBO +0.30% 77 FCF Yield % is 5.90 as of Jun. 27, 2026, which is 47% above its 10-year median of 4.02. GuruFocus rates ASX:EBO with a GF Score™ of 77/100 and a GF Value™ of A$31.49 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 119 Medical Distribution companies, Ebos Group ranks better than 64.71% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ebos Group's Trailing 12-Month Free Cash Flow is A$231 Mil, and Market Cap is A$3,465 Mil. Therefore, Ebos Group's FCF Yield % for today is 5.90%.

The historical rank and industry rank for Ebos Group's FCF Yield % or its related term are showing as below:

ASX:EBO' s FCF Yield % Range Over the Past 10 Years
Min: 2.14   Med: 4.02   Max: 10.29
Current: 5.9


During the past 13 years, the highest FCF Yield % of Ebos Group was 10.29%. The lowest was 2.14%. And the median was 4.02%.

ASX:EBO's FCF Yield % is ranked better than
64.71% of 119 companies
in the Medical Distribution industry
Industry Median: 2.63 vs ASX:EBO: 5.90

Ebos Group's FCF Margin % for the quarter that ended in Dec. 2025 was 0.18%.


Ebos Group FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ebos Group FCF Yield % Related Terms


Ebos Group FCF Yield % Historical Data

* Premium members only.

The historical data trend for Ebos Group's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ebos Group FCF Yield % Chart

Ebos Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.38 2.43 4.51 4.61 5.08

Ebos Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.26 6.77 4.39 6.05 0.50

ASX:EBO vs MCK, COR, CAH: FCF Yield % Comparison

For the Medical Distribution subindustry, Ebos Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ebos Group FCF Yield % vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ebos Group's FCF Yield % falls into.


ASX:EBO
77GF Score
Ebos Group Ltd ASX:EBO
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ebos Group FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ebos Group's FCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=367.435 / 7232.9557
=5.08%

Ebos Group's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=12.22 * 2 / 4846.81464
=0.50%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of 5.90 mean?
Ebos Group (ASX:EBO) has a FCF Yield % of 5.90 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ebos Group and its competitors. This is 47% above median its historical median of 4.02. Over the past decade, Ebos Group's FCF Yield % has ranged from 2.14 to 10.29. According to the industry distribution chart, Ebos Group ranks #42 out of 119 companies in the Medical Distribution industry, placing it in the top 35.3%.
Is Ebos Group's FCF Yield % too high?
Ebos Group's current FCF Yield % of 5.90 is 47% above median its 10-year median of 4.02. Over the past 10 years, this metric has ranged from a low of 2.14 to a high of 10.29. The Medical Distribution industry median FCF Yield % is 2.63. Ebos Group's value of 5.90 is 124.3% above this industry median. Based on the distribution chart, Ebos Group ranks #42 out of 119 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Ebos Group has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's FCF Yield % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #42 out of 119 companies for FCF Yield %. This puts Ebos Group in the upper half of its industry. The industry median FCF Yield % is 2.63. Ebos Group's value of 5.90 is 124.3% above this benchmark. Historically, Ebos Group's own FCF Yield % has ranged from 2.14 to 10.29 over the past decade. While the company's 10-year median is 4.02 vs. the industry median of 2.63, Ebos Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Distribution company?
The median FCF Yield % among Medical Distribution companies is 2.63, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current FCF Yield % of 5.90 is 124.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median FCF Yield % is 2.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current FCF Yield % is 5.90, which is 47% above median its own 10-year median of 4.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Based on GuruFocus' analysis, Ebos Group (ASX:EBO) is currently considered Significantly Undervalued. The stock's GF Value™ is A$31.49, compared to a current price of A$16.76 — trading 46.8% below its estimated fair value. The current FCF Yield % is 5.90, which is 47% above median its 10-year median of 4.02 and 124.3% above the Medical Distribution industry median of 2.63. Ebos Group's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Ebos Group (ASX:EBO), the current FCF Yield % is 5.90 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ebos Group (ASX:EBO) Overvalued in 2026?

Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued. The current stock price of A$16.76 is trading 46.8% below its estimated GF Value™ of A$31.49. GuruFocus considers Ebos Group to be Significantly Undervalued.

Key valuation signals for ASX:EBO:

  • FCF Yield %: 5.90 (47% above median its 10-year median of 4.02)
  • GF Value™: A$31.49 vs. price of A$16.76 (46.8% below fair value)
  • GF Score™: 77/100 with 4 warning signs
  • Industry Position: 124.3% above the Medical Distribution median (#42 of 119)

No single metric tells the full story. See the ASX:EBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ebos Group Business Description

Address 737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
77GF Score

Get the complete analysis for ASX:EBO

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$16.76
Price
A$31.49
GF Value